Structure, function and regulation of outer membrane proteins involved in drug transport in Enterobactericeae: The OmpF/C - TolC Case

Open Microbiology Journal

Volumn 7, Issue SPEC.ISSUE.1, 2013, Pages 22-33

  Masi, Muriel ^a   Pagès, Jean Marie ^b,c  

^a CNRS   (France)

^b Aix Marseille University   (France)

^c COST Action BM0701 ^*  (Belgium)

Author keywords

Antibiotics; Efflux pumps; Membrane permeability; Multidrug resistance; Porins

Indexed keywords

BETA LACTAM ANTIBIOTIC; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOLC PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; CHANNEL GATING; DRUG DESIGN; DRUG POTENCY; DRUG TRANSPORT; ENTEROBACTERIACEAE; HYDROPHILICITY; MEMBRANE PERMEABILITY; MICROBIOLOGICAL PARAMETERS; MULTIDRUG EFFLUX PUMP; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 84876080238     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801307010022     Document Type: Review

References (178)

1. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003; 67: 593-656.
2. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. ColdSpring Harb Perspect Biol 2010; 2:a000414.
3. Delcour AH. Outer membrane permeability and antibiotic resis-tance. Biochim Biophys Acta 2009; 1794: 808-16.
4. Fairman JW, Noinaj N, Buchanan SK. The structural biology of β-barrel membrane proteins: a summary of recent reports. Curr Opin Struct Biol 2011; 21: 523-31.
5. Aguilella VM, Queralt-Martín M, Aguilella-Arzo M, Alcaraz A. Insights on the permeability of wide protein channels: measurement and interpretation of ion selectivity. Integr Biol (Camb) 2011; 3: 159-72.
6. Pagès J.-M. Role of bacterial porins in antibiotic susceptibility ofGram-negative bacteria. In: Benz R, Ed. Bacterial and eukaryotic porins: Structure function and mechanism. Weinheim: Wiley-VCH 2004; pp. 41-59.
7. Nguyen TX, Alegre ER, Kelley ST. Phylogenetic analysis ofgeneral bacterial porins: a phylogenomic case study. J Mol Microbiol Biotechnol 2006; 11: 291-301.
8. Gatsos X, Perry AJ, Anwari K, et al. Protein secretion and outermembrane assembly in Alphaproteobacteria. FEMS Microbiol Rev 2008; 32: 995-1009.
9. Pagès J.-M, James CE, Winterhalter M. The porin and the permeat-ing antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 2008; 6: 893-903.
10. Ceccarelli M, Ruggerone P. Physical insights into permeation ofand resistance to antibiotics in bacteria. Curr Drug Targets 2008; 9: 779-88.
11. Hajjar E, Bessonov A, Molitor A, et al. Toward screening forantibiotics with enhanced permeation properties through bacterial porins. Biochemistry 2010; 49: 6928-35.
12. Nikaido H, Pagès JM. Broad-specificity efflux pumps and their rolein multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 2012; 36: 340-63.
13. Davin-Regli A, Bolla JM, James C, et al. Membrane permeabilityand regulation of drug « influx and efflux » in enterobacterial pathogens. Curr Drug Target 2008; 9: 750-9.
14. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: anupdate. Drugs 2009; 69: 1555-623.
15. Pagès JM, Amaral L. Mechanisms of drug efflux and strategies tocombat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 2009; 1794: 826-33.
16. Cowan SW, Schirmer T, Rummel G, et al. Crystal structuresexplain functional properties of two E. coli porins. Nature 1992; 358: 727-33.
17. Pratt LA, Hsing W, Gibson KE, Silhavy TJ. From acids to osmZ:multiple factors influence synthesis of the OmpF and OmpC porins in Escherichia coli. Mol Microbiol 1996; 20: 911-7.
18. Mizuno T, Mizushima S. Signal transduction and gene regulationthrough the phosphorylation of two regulatory components: the molecular basis for the osmotic regulation of the porin genes. Mol Microbiol 1990; 4: 1077-82.
19. van Alphen W, Lugtenberg B. Influence of osmolarity of thegrowth medium on the outer membrane protein pattern of Escherichia coli. J Bacteriol 1977; 131: 623-30.
20. Villarejo M, Case CC. envZ mediates transcriptional control bylocal anesthetics but is not required for osmoregulation in Escherichia coli. J Bacteriol 1984; 159: 883-7.
21. Heyde M, Portalier R. Regulation of major outer membrane porinproteins of Escherichia coli K12 by pH. Mol Gen Genet 1987; 208: 511-7.
22. Liu X, Ferenci T. Regulation of porin-mediate outer membranepermeability by nutrient limitation in Escherichia coli. J Bacteriol 1998; 180: 3917-22.
23. Pogliano J, Lynch AS, Belin D, Lin EC, Beckwith J. Regulation ofEscherichia coli cell envelope proteins involved in protein folding and degradation by the Cpx two-component system. Genes Dev 1997; 11: 1169-82.
24. Batchelor E, Walthers D, Kenney LJ, Goulian M. The Escherichiacoli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC. J Bacteriol 2005; 187: 5723-31.
25. Price NL, Raivio TL. Characterization of the Cpx regulon in Es-cherichia coli strain MC4100. J Bacteriol 2009; 191: 1798-815.
26. Gerken H, Leiser OP, Bennion D, Misra R. Involvement andnecessity of the Cpx regulon in the event of aberrant beta-barrel outer membrane protein assembly. Mol Microbiol 2010; 75: 1033-46.
27. Alba BM, Gross CA. Regulation of the Escherichia coli sE-dependent envelope stress response. Mol Microbiol 2004, 52: 613-9.
28. Raivio TL, Silhavy TJ. Periplasmic stress and ECF sigma factors. Annu Rev Microbiol 2001; 55: 591-624.
29. Gerken H, Misra R. MzrA-EnvZ interactions in the periplasminfluence the EnvZ/OmpR two-component regulon. J Bacteriol 2010; 192: 6271-8.
30. Mizuno T, Chou MY, Inouye M. A unique mechanism regulatinggene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci USA 1984; 81: 1966-70.
31. Chen S, Zhang A, Blyn LB, Storz G. MicC, a second small-RNAregulator of Omp protein expression in Escherichia coli. J Bacteriol 2004; 186: 6689-97.
32. Castillo-Keller M, Vuong P, Misra R. Novel mechanism of Es-cherichia coli porin regulation. J Bacteriol 2006; 188: 576-86.
33. Douchin V, Bohn C, Bouloc P. Down-regulation of porins by asmall RNA bypasses the essentiality of the regulated intramembrane proteolysis protease RseP in Escherichia coli. J Biol Chem 2006; 281: 12253-9.
34. Bossi L, Figueroa-Bossi N. A small RNA downregulates LamBmaltoporin in Salmonella. Mol Microbiol 2007; 65: 799-810.
35. Johansen J, Eriksen M, Kallipolitis B, Valentin-Hansen P. Down-regulation of outer membrane proteins by noncoding RNAs: unraveling the cAMP-CRP- and sigmaE-dependent CyaR-ompX regulatory case. J Mol Biol 2008; 383: 1-9.
36. Storz G, Opdyke JA, Zhang A. Controlling mRNA stability andtranslation with small, noncoding RNAs. Curr Opin Microbiol 2004; 7: 140-4.
37. Vogel J, Papenfort K. Small non-coding RNAs and the bacterialouter membrane. Curr Opin Microbiol 2006; 9: 605-11.
38. Guillier M, Gottesman S, Storz G. Modulating the outer membranewith small RNAs. Genes Dev 2006; 20: 2338-48.
39. Chubiz LM, Rao CV. Role of the mar-sox-rob regulon in regulatingouter membrane porin expression. J Bacteriol 2011; 193: 2252-60.
40. George AM, Hall RM, Stokes HW. Multidrug resistance in Kleb-siella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 1995; 141: 1909-20.
41. Chollet R, Chevalier J, Bollet C, Pages JM, Davin-Regli A. Ram A is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48: 2518-23.
42. Sulavik MC, Gambino LF, Miller PF. Analysis of the geneticrequirements for inducible multiple-antibiotic resistance associated with the mar locus in Escherichia coli. J Bacteriol 1994; 176: 7754-6.
43. Seoane AS, Levy SB. Characterization of MarR, the repressor ofthe multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol 1995; 177: 3414-9.
44. Bornet C, Chollet R, Malléa M, et al. Imipenem and expression ofmultidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 2003; 301: 985-90.
45. Viveiros M, Dupont M, Rodrigues L, et al. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2007; 2:e365.
46. Masi M, Pagès JM, Pradel E. Production of the cryptic EefABCefflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. J Antimicrob Chemother 200; 57: 1223-1236.
47. Ghisalberti D, Masi M, Pagès JM, Chevalier J. Chloramphenicoland expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 2005; 328: 1113-8.
48. Doménech-Sánchez A, Hernández-Allés S, Martínez-Martínez L, Benedí VJ, Albertí S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol 1999; 181: 2726-32.
49. Tran QT, Mahendran KR, Hajjar E, et al. Implication of porins inbeta-lactam resistance of Providencia stuartii. J Biol Chem 2010; 285: 32273-81.
50. Bornet C, Davin-Regli A, Bosi C, Pagès JM, Bollet C. Imipenemresistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 2000; 38: 1048-52.
51. Rolhion N, Carvalho FA, Darfeuille-Michaud A. OmpC and thesigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. Mol Microbiol 2007; 63: 1684-700.
52. Turner AK, Terry TD, Sack DA, Londoño-Arcila P, Darsley MJ. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun 2001; 69: 4969-79.
53. Tsai YK, Fung CP, Lin JC, et al. Klebsiella pneumoniae outermembrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 2011; 55: 1485-93.
54. Bialek S, Lavigne JP, Chevalier J, et al. Membrane efflux andinflux modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother 2010; 54: 4373-8.
55. Lavigne JP, Sotto A, Nicolas-Chanoine MH, et al. Membranepermeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin Microbiol Infect 2011; 18: 539-45.
56. O'Regan E, Quinn T, Frye JG, et al. Fitness costs and stability of ahigh-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother 2010; 54: 367-74.
57. Hagan CL, Silhavy TJ, Kahne D. β-Barrel membrane proteinassembly by the Bam complex. Annu Rev Biochem 2011; 80: 189-210.
58. Duguay AR, Silhavy TJ. Quality control in the bacterial periplasm. Biochim Biophys Acta 2004; 1694: 121-34.
59. Sklar JG, Wu T, Kahne D, Silhavy TJ. Defining the roles of theperiplasmic chaperones SurA, Skp, and DegP in Escherichia coli. Genes Dev 2007; 21: 2473-84.
60. Ried G, Hindennach I, Henning U. Role of lipopolysaccharide inassembly of Escherichia coli outer membrane proteins OmpA, OmpC, and OmpF. J Bacteriol 1990; 172: 6048-53.
61. Voulhoux R, Bos MP, Geurtsen J, Mols M, Tommassen J. Role ofa highly conserved bacterial protein in outer membrane protein assembly. Science 2003; 299: 262-5.
62. Voulhoux R, Tommassen J. Omp85, an evolutionarily conservedbacterial protein involved in outer-membrane-protein assembly. Res Microbiol 2004; 155: 129-35.
63. Jacob-Dubuisson F, Villeret V, Clantin B, Delattre AS, Saint N. First structural insights into the TpsB/Omp85 superfamily. Biol Chem 2009; 390: 675-84.
64. Wu T, Malinverni J, Ruiz N, Kim S, Silhavy TJ, Kahne D. Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell 2005; 121: 235-45.
65. Sklar JG, Wu T, Gronenberg LS, Malinverni JC, Kahne D, Silhavy TJ. Lipoprotein SmpA is a component of the YaeT complex that assembles outer membrane proteins in Escherichia coli. Proc Natl Acad Sci USA 2007; 104: 6400-5.
66. Malinverni JC, Werner J, Kim S, et al. YfiO stabilizes the YaeTcomplex and is essential for outer membrane protein assembly in Escherichia coli. Mol Microbiol 2006; 61: 151-64.
67. Kim S, Malinverni JC, Sliz P, Silhavy TJ, Harrison SC, Kahne D. Structure and function of an essential component of the outer membrane protein assembly machine. Science 2007; 317: 961-4.
68. Vuong P, Bennion D, Mantei J, Frost D, Misra R. Analysis of YfgLand YaeT interactions through bioinformatics, mutagenesis, and biochemistry. J Bacteriol 2008; 190: 1507-17.
69. Hagan CL, Kim S, Kahne D. Reconstitution of outer membraneprotein assembly from purified components. Science 2010; 328: 890-2.
70. Bennion D, Charlson ES, Coon E, Misra R. Dissection of β-barrelouter membrane protein assembly pathways through characterizing BamA POTRA 1 mutants of Escherichia coli. Mol Microbiol 2010; 77: 1153-71.
71. Knowles TJ, Jeeves M, Bobat S, et al. Fold and function of poly-peptide transport-associated domains responsible for delivering unfolded proteins to membranes. Mol Microbiol 2008; 68: 1216-27.
72. Clantin B, Delattre AS, Rucktooa P, et al. Structure of the mem-brane protein FhaC: a member of the Omp85-TpsB transporter superfamily. Science 2007; 317: 957-61.
73. Delattre AS, Saint N, Clantin B, et al. Substrate recognition by thePOTRA domains of TpsB transporter FhaC. Mol Microbiol 2011; 81: 99-112.
74. Delattre AS, Clantin B, Saint N, Locht C, Villeret V, Jacob-Dubuisson F. Functional importance of a conserved sequence motif in FhaC, a prototypic member of the TpsB/Omp85 superfamily. FEBS J 2010; 277: 4755-65.
75. Tellez R Jr, Misra R. Substitutions in the BamA β-barrel domainovercome the conditional lethal phenotype of a ΔbamB ΔbamE strain of Escherichia coli. J Bacteriol 2012; 194: 317-24.
76. Vinson HM, Gautam A, Olet S, Gibbs PS, Barigye R. Molecularanalysis of porin gene transcription in heterogenotypic multidrugresistant Escherichia coli isolates from scouring calves. J Antimicrob Chemother 2010; 65: 1926-35.
77. Srinivas N, Jetter P, Ueberbacher BJ, et al. Peptidomimetic antibi-otics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 2010; 327: 1010-3.
78. Wu T, McCandlish AC, Gronenberg LS, Chng SS, Silhavy TJ, Kahne D. Identification of a protein complex that assembles lipopolysaccharide in the outer membrane of Escherichia coli. Proc Natl Acad Sci USA 2006; 103: 11754-9.
79. Chng SS, Ruiz N, Chimalakonda G, Silhavy TJ, Kahne D. Characterization of the two-protein complex in Escherichia coli responsible for lipopolysaccharide assembly at the outer membrane. Proc Natl Acad Sci USA 2010; 107: 5363-8.
80. Lou KL, Saint N, Prilipov A, et al. Structural and functional characterization of OmpF porin mutants selected for larger pore size. I. Crystallographic analysis. J Biol Chem 1996; 271: 20669-75.
81. Dutzler R, Rummel G, Albertí S, et al. Crystal structure and func-tional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae. Structure 1999; 7: 425-34.
82. Baslé A, Rummel G, Storici P, Rosenbusch JP, Schirmer T. Crystalstructure of osmoporin OmpC from E. coli at 2.0 A. J Mol Biol 2006; 362: 933-42.
83. Dé E, Baslé A, Jaquinod M, et al. A new mechanism of antibioticresistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol 2001; 41: 189-98.
84. Thiolas A, Bornet C, Davin-Régli A, Pagès J-M, Bollet C. Resis-tance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun 2004; 317: 851-856.
85. García-Fernández A, Miriagou V, Papagiannitsis CC, et al. Anertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 2010; 54: 4178-84.
86. Saint N, Lou KL, Widmer C, Luckey M, Schirmer T, Rosenbusch JP. Structural and functional characterization of OmpF porin mutants selected for larger pore size. II. Functional characterization. J Biol Chem 1996; 271: 20676-80.
87. Jeanteur D, Schirmer T, Fourel D, et al. Structural and functionalalterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. Proc Natl Acad Sci USA 1994; 91: 10675-9.
88. Simonet V, Malléa M, Pagès JM. Substitutions in the eyelet regiondisrupt cefepime diffusion through the Escherichia coli OmpF channel. Antimicrob Agents Chemother 2000; 44: 311-5.
89. Phale PS, Philippsen A, Widmer C, Phale VP, Rosenbusch JP,Schirmer T. Role of charged residues at the OmpF porin channel constriction probed by mutagenesis and simulation. Biochemistry 2001; 40: 6319-25.
90. Bredin J, Saint N, Malléa M, et al. Alteration of pore properties ofEscherichia coli OmpF induced by mutation of key residues in anti-loop 3 region. Biochem J 2002; 363: 521-8.
91. Nestorovich EM, Danelon C, Winterhalter M, Bezrukov SM.Designed to penetrate: time-resolved interaction of single antibiotic molecules with bacterial pores. Proc Natl Acad Sci USA 2002; 99: 9789-94.
92. Danelon C, Nestorovich EM, Winterhalter M, Ceccarelli M, Bez-rukov SM. Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation. Biophys J 2006; 90: 1617-27.
93. James CE, Mahendran KR, Molitor A, et al. How beta-lactamantibiotics enter bacteria: a dialogue with the porins. PLoS ONE 2009; 4:e5453
94. Kumar A, Hajjar E, Ruggerone P, Ceccarelli M. Molecular simula-tions reveal the mechanism and the determinants for ampicillin translocation through OmpF. J Phys Chem B 2010; 114: 9608-16.
95. Kumar A, Hajjar E, Ruggerone P, Ceccarelli M. Structural anddynamical properties of the porins OmpF and OmpC: insights from molecular simulations. J Phys Condens Matter 2010; 22: 454125.
96. Vidal S, Bredin J, Pagès JM, Barbe J. Beta-lactam screening byspecific residues of the OmpF eyelet. J Med Chem 2005; 48: 1395-400.
97. Misra R, Benson SA. Genetic identification of the pore domain ofthe OmpC porin of Escherichia coli K-12. J Bacteriol 1988; 170: 3611-7.
98. Lou H, Chen M, Black SS, et al. Altered antibiotic transport inOmpC mutants isolated from a series of clinical strains of multidrug resistant E. coli. PLoS ONE 2011; 6: e25825.
99. Davies JK, Reeves P. Colicin tolerance and map location of conju-gation-deficient mutants. J Bacteriol 1975; 123: 372-3.
100. Wandersman C, Delepelaire P. TolC, an Escherichia coli outermembrane protein required for hemolysin secretion. Proc Natl Acad Sci USA 1990; 87: 4776-80.
101. Delepelaire P. Type I secretion in gram-negative bacteria. BiochimBiophys Acta 2004; 1694: 149-61.
102. Fralick JA. Evidence that TolC is required for functioning of theMar/AcrAB efflux pump of Escherichia coli. J Bacteriol 1996; 178: 5803-5.
103. German GJ, Misra R. The TolC protein of Escherichia coli servesas a cell-surface receptor for the newly characterized TLS bacteriophage. J Mol Biol 2001; 308: 579-85.
104. Pérez A, Poza M, Fernández A, et al. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 2012; 56: 2084-90.
105. Minato Y, Siefken RL, Häse CC. TolC affects virulence geneexpression in Vibrio cholerae. J Bacteriol 2011; 193: 5850-2.
106. Platz GJ, Bublitz DC, Mena P, Benach JL, Furie MB, Thanassi DG. A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells. Infect Immun 2010; 78: 1022-31.
107. Ferhat M, Atlan D, Vianney A, Lazzaroni JC, Doublet P, Gilbert C.The TolC protein of Legionella pneumophila plays a major role in multi-drug resistance and the early steps of host invasion. PLoS ONE 2009; 4(11):e7732.
108. Kadzhaev K, Zingmark C, Golovliov I, et al. Identification ofgenes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS ONE 2009; 4(5):e5463.
109. Webber MA, Bailey AM, Blair JM, et al. The global consequenceof disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 2009; 191: 4276-85.
110. Bunikis I, Denker K, Ostberg Y, Andersen C, Benz R, Bergström S. An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds. PLoS Pathog 2008; 4(2):e1000009.
111. Gil H, Platz GJ, Forestal CA, et al. Deletion of TolC orthologs inFrancisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A 2006; 103: 12897-902.
112. Koronakis V, Eswaran J, Hughes C. Structure and function ofTolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem 2004; 73: 467-89.
113. Schweizer HP. Efflux as a mechanism of resistance to antimicrobi-als in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003; 2: 48-62.
114. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystalstructure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 2000; 405: 914-9.
115. Akama H, Kanemaki M, Yoshimura M, et al. Crystal structure ofthe drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. J Biol Chem 2004; 279: 52816-9.
116. Federici L, Du D, Walas F, et al. The crystal structure of the outermembrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 A resolution. J Biol Chem 2005; 280: 15307-14.
117. Kulathila R, Kulathila R, Indic M, van den Berg B. Crystal struc-ture of Escherichia coli CusC, the outer membrane component of a heavy metal efflux pump. PLoS ONE 2011; 6: e15610.
118. Andersen C. Channel-tunnels: outer membrane components of typeI secretion systems and multidrug efflux pumps of Gram-negative bacteria. Rev Physiol Biochem Pharmacol 2003; 147: 122-65.
119. Nouwen N, Stahlberg H, Pugsley AP, Engel A. Domain structureof secretin PulD revealed by limited proteolysis and electron microscopy. EMBO J 2000; 19: 2229-36.
120. Buchanan SK, Smith BS, Venkatramani L, et al. Crystal structureof the outer membrane active transporter FepA from Escherichia coli. Nat Struct Biol 1999; 6: 56-63.
121. Locher KP, Rees B, Koebnik R, et al. D Transmembrane signalingacross the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell 1998; 95: 771-8.
122. Wong KK, Brinkman FS, Benz RS, Hancock RE. Evaluation of astructural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance. J Bacteriol 2001; 183: 367-74.
123. Andersen C, Hughes C, Koronakis V. Electrophysiological behavior of the TolC channel-tunnel in planar lipid bilayers. J Membr Biol 2002; 185: 83-92.
124. Masi M, Saint N, Molle G, Pagès JM. The Enterobacter aerogenesouter membrane efflux proteins TolC and EefC have different channel properties. Biochim Biophys Acta 2007; 1768: 2559-67.
125. Andersen C, Koronakis E, Bokma E, et al. Transition to the openstate of the TolC periplasmic tunnel entrance. Proc Natl Acad Sci USA 2002; 99: 11103-8.
126. Eswaran J, Hughes C, Koronakis V. Locking TolC entrance helicesto prevent protein translocation by the bacterial type I export apparatus. J Mol Biol 2003; 327: 309-15.
127. Werner J, Augustus AM, Misra R. Assembly of TolC, a structurallyunique and multifunctional outer membrane protein of Escherichia coli K-12. J Bacteriol 2003; 185: 6540-7.
128. Masi M, Duret G, Delcour AH, Misra R. Folding and trimerizationof signal sequence-less mature TolC in the cytoplasm of Escherichia coli. Microbiology 2009; 155: 1847-57.
129. Werner J, Misra R. YaeT (Omp85) affects the assembly of lipid-dependent and lipid-independent outer membrane proteins of Escherichia coli. Mol Microbiol 2005; 57: 1450-9.
130. Tokuda H. Biogenesis of outer membranes in Gram-negativebacteria. Biosci Biotechnol Biochem 2009; 73: 465-73.
131. Li XZ, Poole K. Mutational analysis of the OprM outer membranecomponent of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 2001; 183: 12-27.
132. Nakajima A, Sugimoto Y, Yoneyama H, Nakae T. Localization ofthe outer membrane subunit OprM of resistance-nodulation-cell division family multicomponent efflux pump in Pseudomonas aeruginosa. J Biol Chem 2000; 275: 30064-8.
133. Gerken H, Misra R. Genetic evidence for functional interactionsbetween TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Mol Microbiol 2004; 54: 620-31.
134. Vediyappan G, Borisova T, Fralick JA. Isolation and characteriza-tion of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli. J Bacteriol 2006; 188: 3757-62.
135. Bokma E, Koronakis E, Lobedanz S, Hughes C, Koronakis V.Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase. FEBS Lett 2006; 580: 5339-43.
136. Lobedanz S, Bokma E, Symmons MF, Koronakis E, Hughes C, Koronakis V. A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug efflux pumps. Proc Natl Acad Sci USA 2007; 104: 4612-7.
137. Ge Q, Yamada Y, Zgurskaya H. The C-terminal domain of AcrA isessential for the assembly and function of the multidrug efflux pump AcrAB-TolC. J Bacteriol 2009; 191: 4365-71.
138. Weeks JW, Celaya-Kolb T, Pecora S, Misra R. AcrA suppressoralterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening. Mol Microbiol 2010; 75: 1468-83.
139. Kim HM, Xu Y, Lee M, et al. Functional relationships between theAcrA hairpin tip region and the TolC aperture tip region for the formation of the bacterial tripartite efflux pump AcrAB-TolC. J Bacteriol 2010; 192: 4498-503.
140. Bavro VN, Pietras Z, Furnham N, et al. Assembly and channelopening in a bacterial drug efflux machine. Mol Cell 2008; 30: 114-21.
141. Pei XY, Hinchliffe P, Symmons MF, et al. Structures of sequentialopen states in a symmetrical opening transition of the TolC exit duct. Proc Natl Acad Sci USA 2011; 108: 2112-7.
142. Tamura N, Murakami S, Oyama Y, Ishiguro M, Yamaguchi A. Direct interaction of multidrug efflux transporter AcrB and outer membrane channel TolC detected via site-directed disulfide crosslinking. Biochemistry 2005; 44: 11115-21.
143. Higgins MK, Bokma E, Koronakis E, Hughes C, Koronakis V. Structure of the periplasmic component of a bacterial drug efflux pump. Proc Natl Acad Sci USA 2004; 101: 9994-9.
144. Akama H, Matsuura T, Kashiwagi S, et al. Crystal structure of themembrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J Biol Chem 2004; 279: 25939-42.
145. Misra R, Bavro VN. Assembly and transport mechanism of tripartite drug efflux systems. Biochim Biophys Acta 2009; 1794: 817-25.
146. Symmons MF, Bokma E, Koronakis E, Hughes C, Koronakis V.The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc Natl Acad Sci USA 2009; 106: 7173-8.
147. Xu Y, Moeller A, Jun SY, et al. Assembly and channel opening ofthe outer membrane protein in tripartite drug efflux pumps of Gram-negative bacteria. J Biol Chem 2012; 287: 11740-50.
148. Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamagu-chi A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 2006; 443: 173-9.
149. Seeger MA, Schiefner A, Eicher T, Verrey F, Diederichs K, Pos KM. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 2006; 313: 1295-8.
150. Murakami S. Multidrug efflux transporter, AcrB--the pumpingmechanism. Curr Opin Struct Biol 2008; 18: 459-65.
151. Aono R, Tsukagoshi N, Yamamoto M. Involvement of outer mem-brane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J Bacteriol 1998; 180: 938-44.
152. Barbosa TM, Levy SB. Differential expression of over 60 chromo-somal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 2000; 182: 3467-74.
153. Martin RG, Rosner JL. Genomics of the marA/soxS/rob regulon ofEscherichia coli: identification of directly activated promoters by application of molecular genetics and informatics to microarray data. Mol Microbiol 2002; 44: 1611-24.
154. Martin RG, Gillette WK, Rosner JL. Promoter discrimination bythe related transcriptional activators MarA and SoxS: differential regulation by differential binding. Mol Microbiol 2000; 35: 623-34.
155. Zhang A, Rosner JL, Martin RG. Transcriptional activation byMarA, SoxS and Rob of two tolC promoters using one binding site: a complex promoter configuration for tolC in Escherichia coli. Mol Microbiol 2008; 69: 1450-5.
156. Eguchi Y, Oshima T, Mori H, et al. Transcriptional regulation ofdrug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology 2003; 149: 2819-28.
157. Groisman EA. The pleiotropic two-component regulatory systemPhoP-PhoQ. J Bacteriol 2001; 183: 1835-42.
158. Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction ofantibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol 1993; 175: 7856-62.
159. Demple B. Redox signaling and gene control in the Escherichiacoli soxRS oxidative stress regulon-a review. Gene 1996; 179: 53-7.
160. Rosner JL, Dangi B, Gronenborn AM, Martin RG. Posttranscrip-tional activation of the transcriptional activator Rob by dipyridyl in Escherichia coli. J Bacteriol 2002; 184: 1407-16.
161. Rosenberg EY, Bertenthal D, Nilles ML, Bertrand KP, Nikaido H. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol 2003; 48: 1609-19.
162. Nikaido E, Yamaguchi A, Nishino K. AcrAB multidrug effluxpump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 2008; 283: 24245-53.
163. Bailey AM, Ivens A, Kingsley R, Cottell JL, Wain J, Piddock LJ. Ram A, A member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol 2010; 192: 1607-16.
164. Sulavik MC, Houseweart C, Cramer C, et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 2001; 45: 1126-36.
165. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 2011; 55: 921-4.
166. Alekshun MN, Levy SB. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 1999; 7:410-3.
167. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19:382-402.
168. Rosner JL, Martin RG. An excretory function for the Escherichia coli outer membrane pore TolC: upregulation of marA and soxStranscription and Rob activity due to metabolites accumulated in tolC mutants. J Bacteriol 2009; 19: 5283-92.
169. Lee HH, Molla MN, Cantor CR, Collins JJ. Bacterial charity work leads to population-wide resistance. Nature 2010; 467: 82-5.
170. Ricci V, Tzakas P, Buckley A, Piddock LJ. Ciprofloxacin resistantSalmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
171. Yan M, Sahin O, Lin J, Zhang Q. Role of the Cme ABC efflux pump in the emergence of fluoroquinolone-resistant Campylobac-ter under selection pressure. J Antimicrob Chemother 2006; 58: 1154-9.
172. Quinn T, O'Mahony R, Baird AW, Drudy D, Whyte P, Fanning S. Multi-drug resistance in Salmonella enterica: efflux mechanismsand their relationships with the development of chromosomal resistance gene clusters. Curr Drug Targets 2006; 7: 849-60.
173. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 2010; 8: 260-71.
174. Martínez JL, Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 768-89.
175. Wiedenbeck J, Cohan FM. Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches. FEMS Microbiol Rev 2011; 35: 957-76.
176. Bolla JM, Alibert-Franco S, Handzlik J, et al. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett 2011; 585: 1682-90.
177. Giamarellou H. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents 2010; 36: S50-4.
178. Hurdle JG, O'Neill AJ, Chopra I, Lee RE. Targeting bacterialmembrane function: an underexploited mechanism for treating per sistent infections. Nat Rev Microbiol 2011; 9: 62-75.